Fundraising FoxTRACT Therapeutics
Chicago, US · Delaware corporation
Find your way into TRACT Therapeutics
Sign up to see every warm intro you have to TRACT Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TRACT Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PC
Peter CourossiExecutive
Board
JL
Joseph LeventhalBoard director
NR
Norbert RiedelBoard director
Reported raises · per SEC filings
Form D private placements$15M disclosed across 1 round · 2019
▶$15MraisedApr 2019 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedApr 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LeventhalDirector
- Peter CourossiExecutive Officer, Director
- Gretchen JohnsonExecutive Officer, Director
- Norbert RiedelDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has TRACT Therapeutics raised?
- TRACT Therapeutics has disclosed $15M raised across 1 round.
- Where is TRACT Therapeutics headquartered?
- TRACT Therapeutics is headquartered in Chicago, US.